GU Specialists




Ronald C. Chen, MD, MPH

Joe and Jean Brandmeyer Endowed Chair, Department of Radiation Oncology
Professor, Department of Radiation Oncology
Clinical Service Chief, Department of Radiation Oncology
Associate Director of Health Equity, University of Kansas Cancer Center 
Radiation Oncology

"Dr. Chen is the Brandmeyer Chair and Professor of Radiation Oncology. An internationally renowned radiation oncologist, Dr. Chen specializes in the treatment of prostate and bladder cancers, and uses the latest technology - including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and brachytherapy. Dr. Chen has helped write many of the national standards and guidelines on the treatment of prostate cancer, and lectures across the US and internationally on the treatment of prostate and bladder cancers. He is a leader in the American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO), and several other national organizations."

"Dr. Chen is a GU radiation oncologist with particular clinical interests in prostate and bladder cancers. He is a health services researcher, with research focus on the quality of life in cancer survivors, comparative effectiveness of different treatment approaches for prostate cancer, and patterns of care. Dr. Chen previously was the director of the UNC Cyberknife program and has clinical expertise in using stereotactic body radiation therapy for the primary treatment of tumors and also for treatment of metastatic sites."






Jeff Michalski, MD, MBA, FASTRO

Professor and Vice Chair of Radiation Oncology
Washington University School of Medicine


Dr. Michalski is the Carlos Perez Distinguished Professor, Vice-Chairman of the Department of Radiation Oncology, Director of the Clinical Sciences Division, and Chief of the Genitourinary Service. Dr. Michalski is Chairman of the Radiation Oncology Committee of the NRG Oncology Group, and is a member of the Bladder Cancer Panel of the National Comprehensive Cancer Network. He is Co-Chair of the NCI Genitourinary Cancers Steering Committee. He is a member of the Siteman Cancer Center at Washington University and Barnes-Jewish Hospital, and is the Medical Director of the center’s Clinical Trials Core. Dr. Michalski is a member of the ASTRO Board of Directors, currently serving as the Secretary/Treasurer. His research interests include radiation dose escalation in the management of prostate cancer; conformal therapy to reduce toxicity in late neuro-cognitive effects in children with medulloblastoma; and assessment of quality of life in survivors of adult and childhood malignancies.